past
year
concept
reninangiotensinsystem
ra
monolith
endocrin
system
reflect
primarili
interact
peptid
angiotensin
ii
ang
ii
subtyp
undergon
extens
revis
emerg
view
altern
pathway
within
ra
may
function
antagon
ang
axi
may
trace
back
character
receptor
subtyp
identif
heptapeptid
de
angiotensin
ii
angiotensin
ang
circul
variou
tissu
sinc
time
elabor
distinct
biochem
compon
compris
ang
axi
firmli
establish
identif
uniqu
receptor
ang
gprotein
coupl
ma
receptor
select
antagonist
agonist
receptor
angiotensin
ii
convert
enzym
catalyz
process
ang
ii
ang
addit
identif
compon
ang
system
recognit
variou
signal
pathway
includ
nitric
oxid
prostaglandin
cellular
phosphatas
stimul
peptid
although
earli
studi
ang
primarili
sought
establish
role
ang
regul
blood
pressur
particularli
endogen
level
peptid
increas
markedli
follow
angiotensin
convert
enzym
ace
blockad
pressureindepend
action
ang
axi
consid
perhap
equal
import
inde
benefici
action
ang
system
encompass
variou
patholog
cancer
antiprolif
action
peptid
diabet
cellular
effect
stem
cell
turn
defici
ang
contribut
autonom
dysfunct
appar
hypertens
age
ang
defici
hypertens
restor
ace
inhibitor
treatment
chronic
ang
replac
breadth
effect
surpris
ra
tissu
system
whose
protein
peptid
compon
express
essenti
everi
organ
whose
action
implic
numer
physiolog
event
influenc
renal
neuron
cardiac
pancreat
vascular
adren
pituitari
cognit
age
inflammatori
reproduct
function
ang
axi
ra
increasingli
recogn
key
regulatori
pathway
variou
tissu
cell
counterbalanc
ang
axi
evid
well
review
consid
current
literatur
ma
receptor
axi
regard
sourc
ang
intracellular
express
system
emerg
role
pathway
fetal
program
event
cardiovascular
dysfunct
final
evid
sexdepend
regul
function
ang
axi
angiotensinogen
glycosyl
protein
primarili
synthes
secret
liver
well
tissu
sole
precursor
angiotensin
peptid
known
substrat
aspartyl
proteas
renin
angiotensinogen
releas
decapeptid
ang
aminotermin
portion
protein
figur
ang
cleav
ace
form
bioactiv
peptid
ang
ii
earli
studi
reveal
endogen
level
ang
ang
markedli
increas
follow
administr
ace
inhibitor
augment
respons
ang
suggest
circul
peptid
may
contribut
benefici
action
inhibit
ace
pathway
addit
reduc
endogen
level
ang
ii
increas
ang
presenc
ace
blockad
necessit
process
pathway
independ
format
ang
ii
sever
studi
subsequ
show
endopeptidas
neprilysin
contribut
circul
level
ang
anim
chronic
treat
variou
ace
inhibitor
ang
infus
normotens
wki
hypertens
spontan
hypertens
rat
shr
treat
ace
inhibitor
lisinopril
result
higher
plasma
level
ang
coadministr
neprilysin
inhibitor
prolyl
oligopeptidas
pop
inhibitor
zprolyl
prolin
abolish
circul
level
peptid
moreov
acut
infus
similar
dose
ang
ii
increas
circul
ang
either
control
lisinopriltr
wki
shr
increas
ang
follow
ace
blockad
reflect
reduct
ang
metabol
altern
process
ang
tissuespecif
endopeptidas
regard
pereira
et
al
recent
demonstr
endopeptidas
thimet
oligopeptidas
may
contribut
format
ang
rat
hippocampu
interestingli
investig
report
higher
express
peptidas
ma
receptor
rat
model
tempor
lobe
epilepsi
suggest
possibl
role
ang
ma
axi
central
patholog
inde
studi
support
earlier
report
direct
process
ang
ang
thimet
oligopeptidas
vascular
smooth
muscl
cell
rat
hindlimb
perfus
system
apart
endopeptidas
process
ang
ang
ang
variou
monocarboxypeptidas
includ
prolyl
carboxypeptidas
pcp
pop
ace
homolog
gener
ang
directli
ang
ii
emphas
pcp
requir
acid
ph
optimum
activ
may
contribut
lysosom
pathway
metabol
intern
ang
ii
process
ang
ii
ang
urin
continu
primari
focu
given
abil
effect
metabol
ang
ii
gener
ang
exhibit
effici
constant
vmaxkm
kcat
ang
ii
higher
pc
pop
regard
solubl
form
util
therapeut
agent
reduc
blood
pressur
attenu
target
organ
damag
hypertens
diabet
anim
model
mrna
express
increas
brain
medulla
follow
longterm
blockad
unclear
whether
benefici
effect
administr
reflect
reduct
ang
ii
enhanc
format
ang
increas
ratio
ang
ang
ii
moreov
turner
colleagu
report
solubl
attenu
integrindepend
stimul
focal
adhes
kinas
fak
increas
express
akt
kinas
suggest
peptidas
may
direct
cellular
effect
apart
peptidas
activ
addit
function
role
catalyz
convers
ang
ii
ang
peptidas
may
serv
biomark
renal
cardiac
patholog
two
studi
type
streptozotocininduc
type
ii
dbdb
mice
diabet
model
report
earli
increas
urinari
excret
enhanc
excret
dbdb
mice
close
correl
increas
albuminuria
proteinuria
moreov
chronic
treatment
insulinsensit
agent
rosiglitazon
improv
metabol
balanc
dbdb
mice
reduc
excret
albumin
contrast
reduct
urinari
level
increas
renal
express
dbdb
mous
alter
rosiglitazon
may
reflect
ad
therapeut
benefit
maintain
peptidas
diabet
kidney
import
aspect
two
latter
studi
suggest
diabet
kidney
develop
tissu
injuri
necessarili
interpret
aris
deficit
express
inde
increas
tissu
urinari
level
patholog
condit
may
reflect
compensatori
respons
alter
balanc
ang
ii
ang
pathway
within
particular
tissu
cell
type
regard
deleteri
effect
inhibitor
knockdown
enzym
may
particularli
evid
condit
enhanc
express
circul
level
typic
low
detect
also
increas
experiment
condit
diabet
show
model
diabet
hypertens
circul
activ
increas
fivefold
femal
rat
howev
serum
ace
activ
also
increas
suggest
potenti
benefici
effect
higher
may
offset
ace
act
increas
ang
ii
metabol
ang
inde
plasma
level
ang
chang
diabet
despit
mark
increas
activ
moreov
circul
ace
activ
substanti
higher
assess
similar
incub
substrat
condit
enzym
dbdb
mice
infus
exogen
markedli
increas
serum
level
enzym
alter
urinari
suggest
enzym
readili
filter
glomerulu
one
mechan
increas
urinari
excret
regul
shed
enzym
apic
face
proxim
tubul
figur
studi
lambert
colleagu
origin
report
disintegrin
metalloproteinas
secretas
respons
releas
subsequ
report
identifi
specif
sequenc
juxtamembran
stalk
hydrolyz
releas
peptidas
human
pulmonari
epitheli
cell
proxim
epitheli
cell
dbdb
mous
kidney
extens
overlap
immunostain
moreov
rosiglitazon
treatment
attenu
express
may
contribut
reduc
shed
tubular
fluid
subsequ
excret
urin
addit
shed
may
influenc
tissu
damag
releas
tether
inflammatori
factor
egf
subsequ
activ
respect
receptor
autocrin
paracrin
manner
express
apic
membran
tubul
contribut
regul
local
concentr
ang
ii
increas
may
lead
inflammatori
fibrot
event
enhanc
ang
signal
well
increas
cytokin
growth
factor
activ
figur
lazartigu
colleagu
report
knockdown
brain
docasalt
mice
reduc
blood
pressur
increas
tissu
express
model
neurogen
hypertens
benefit
knockdown
may
reflect
reduct
ang
ii
brain
howev
direct
effect
releas
egf
cytokin
discount
inde
transactiv
egf
receptor
egfr
signal
pathway
key
signal
event
ang
pathway
increas
shed
may
also
reduc
level
ang
attenu
inhibitori
action
ang
axi
proinflammatori
profibrot
pathway
akhtar
et
al
recent
report
ang
attenu
egfr
activ
respons
ang
ii
well
reduc
extent
renal
injuri
diabet
shr
moreov
increas
evid
suggest
one
primari
pathway
activ
ang
stimul
variou
cellular
phosphatas
ptp
includ
may
attenu
activ
kinasedepend
pathway
figur
nagata
colleagu
identifi
novel
endogen
angiotensin
peptid
term
ang
contain
first
amino
acid
ntermin
sequenc
rat
angiotensinogen
figur
investig
develop
antibodi
direct
amino
carboxyltermin
sequenc
ang
demonstr
express
ang
essenti
tissu
contain
ang
ii
highest
level
intestin
brain
heart
plasma
kidney
rat
differenti
express
ang
evid
heart
kidney
shr
normotens
control
wistar
kyoto
strain
wki
antibodi
specif
ctermin
sequenc
rat
ang
includ
reveal
select
stain
cardiac
myocyt
proxim
tubul
cell
kidney
site
hydrolysi
format
ang
rat
angiotensinogen
occur
residu
distinct
sequenc
cleav
renin
form
ang
thu
gener
ang
like
nonrenin
depend
pathway
may
appar
condit
low
suppress
renin
activ
particularli
use
select
renin
inhibitor
similar
ang
ang
hydrolyz
bond
ace
chymas
form
ang
ii
convers
ang
ang
ii
ace
circul
consist
acut
increas
blood
pressur
follow
infus
ang
normotens
rat
well
blockad
pressor
respons
either
ace
inhibitor
antagonist
arnold
et
al
also
find
central
ang
administr
attenu
baroreflex
sensit
respons
block
either
ace
inhibitor
antagonist
moreov
neutral
ang
intracerebroventricular
icv
infus
affinitypurifi
antibodi
reduc
blood
pressur
hypertens
rat
consist
biochem
immunocytochem
evid
ang
rat
brain
knowledg
latter
studi
isa
colleagu
report
date
demonstr
endogen
role
ang
ang
axi
recent
demonstr
ang
may
altern
substrat
gener
ang
kidney
isol
cortic
membran
kidney
hypertens
rat
process
ang
ang
ang
observ
similar
pattern
metabol
use
recombin
form
mous
human
neprilysin
select
neprilysin
inhibitor
abolish
format
ang
note
peak
correspond
ang
process
ang
cortic
membran
also
abolish
neprilysin
inhibitor
suggest
peptid
may
intermedi
process
ang
ang
studi
also
show
circul
renal
renin
metabol
ang
particularli
presenc
ace
inhibitor
lisinopril
impli
peptid
lack
minim
sequenc
recognit
renin
bujakgizycka
colleagu
demonstr
gener
ang
rat
aorta
homogen
serin
peptidas
use
ang
substrat
howev
extent
activ
process
angiotensinogen
protein
ang
current
known
detect
convers
ang
ang
serum
would
consist
lack
solubl
form
neprilysin
circul
signific
level
ang
suggest
absenc
process
carboxypeptidas
feasibl
ang
may
potenti
substrat
ang
initi
convers
ang
subsequ
process
ang
ang
ace
howev
ace
activ
far
higher
circul
ang
format
ang
ang
like
reflect
endopeptidas
activ
although
studi
requir
discern
endogen
pathway
format
process
ang
peptid
constitut
potenti
substrat
convers
either
activ
product
ang
ii
ang
addit
precursor
ang
peptid
may
serv
precursor
activ
form
santo
colleagu
recent
identifi
endogen
analog
ang
aspart
acid
residu
decarboxyl
alanin
ala
form
figur
analog
also
term
almandin
may
also
potenti
aris
proteolyt
process
endogen
ii
ang
similar
ang
induc
relax
isol
aortic
vessel
chronic
infus
analog
lower
blood
pressur
interestingli
vascular
effect
block
typic
receptor
antagonist
ma
receptor
attenu
receptor
antagonist
studi
show
stimul
masrel
receptor
mrgd
interact
ma
receptor
identif
human
circul
isol
heart
perfus
system
achiev
hplcmass
spectrometri
approach
worth
note
avail
direct
ria
elisa
assay
distinguish
form
ang
sinc
isoform
share
ident
ctermin
sequenc
typic
recogn
immunoreact
antibodi
thu
initi
separ
step
hplc
combin
convent
immunoreact
assay
requir
routin
detect
quantifi
differ
form
ang
circul
tissu
potenti
import
find
may
reflect
greater
divers
ang
axi
regard
identif
novel
ligand
receptor
contribut
vascular
tone
moreov
antagonist
antagon
action
mrgd
receptor
may
explain
appar
interact
ang
receptor
note
sever
studi
although
distinct
either
ang
ala
analog
jankowski
et
al
identifi
anoth
endogen
ligand
receptor
human
serum
term
angioprotectin
peptid
resembl
octapeptid
ang
ii
substitut
pro
glu
first
two
ntermin
residu
form
ii
despit
fact
angioprotectin
contain
residu
consid
essenti
action
ang
ii
peptid
lack
vasoconstrictor
activ
isol
aortic
ring
howev
peptid
induc
dosedepend
vasorelax
isol
vessel
absent
vessel
masknockout
mice
well
acut
reduc
blood
pressur
shr
moreov
ii
stimul
format
mastransfect
cho
cell
control
cell
final
studi
present
evid
local
format
ii
ang
ii
human
endotheli
cell
enhanc
addit
exogen
prolin
glutam
acid
suggest
posttranscript
modif
ang
ii
known
degre
ii
process
carboxypeptidas
ang
analog
whether
function
activ
either
ma
mrgd
receptor
also
unclear
extent
convent
immunoreact
assay
ang
ii
detect
endogen
ii
plasma
tissu
given
ident
ctermin
sequenc
circul
level
ii
ang
ii
human
ang
ii
analog
increas
fivefold
patient
endstag
renal
diseas
may
perhap
reflect
compensatori
respons
patholog
condit
endogen
level
ang
influenc
access
process
enzym
carboxypeptidas
endopeptidas
neprilysin
thimet
oligopeptidas
prolyl
endopeptidas
oligopeptidas
level
ang
also
depend
peptidas
metabol
peptid
similar
bradykinin
substanc
p
ace
play
signific
role
hydrolysi
ang
pentapeptid
ang
circul
proxim
tubul
kidney
cortex
figur
ace
inhibit
increas
halflif
ang
sixfold
circul
necessari
demonstr
accumul
ang
ang
ang
iidepend
pathway
renal
proxim
tubul
thu
mechan
increas
level
ang
follow
ace
inhibitor
treatment
reflect
protect
peptid
ace
hydrolysi
ang
shunt
ang
ang
endopeptidas
pathway
neprilysin
thimet
oligopeptidas
rel
littl
inform
peptidas
particip
metabol
ang
ace
recent
detect
endopeptidas
activ
cerebrospin
fluid
csf
sheep
metabol
ang
bond
yield
ang
constitut
major
ang
degrad
activ
csf
although
ident
peptidas
current
unknown
activ
insensit
inhibitor
neprilysin
thimet
oligopeptidas
neurolysin
ang
peptidas
activ
abolish
mercurycompound
pchloromercuribenzo
pcmb
aminophenylmercuriacet
apma
well
chelat
agent
ophenanthrolin
edta
cystein
epoxid
inhibitor
suggest
metallopeptidaselik
activ
csf
regul
csf
peptidas
describ
proceed
section
fetal
program
ra
tradit
view
endocrin
system
wherebi
circul
renin
catalyz
enzymat
cascad
form
activ
peptid
product
howev
appar
multipl
tissu
contain
necessari
compon
local
gener
angiotensin
peptid
tissu
system
may
releas
precursor
angiotensinogen
intermedi
product
ang
ang
activ
peptid
ang
ii
ang
bind
directli
cell
surfac
receptor
autocrin
paracrin
manner
robertson
khairallah
report
year
ago
local
ang
ii
bind
site
chromatin
fraction
vascular
smooth
muscl
cell
cardiomyocyt
suggest
intracellular
site
action
ang
ii
sever
laboratori
subsequ
identifi
ang
ii
receptor
use
classic
receptor
bind
techniqu
nuclei
isol
liver
eggena
colleagu
demonstr
ang
ii
stimul
mrna
transcript
angiotensinogen
renin
pdgf
isol
liver
nuclei
suggest
nuclear
bind
site
function
capabl
directli
mediat
gene
express
moreov
receptor
also
evid
nuclei
isol
cortic
medullari
area
rat
kidney
ang
stimul
isol
renal
nuclei
increas
mrna
express
angiotensinogen
sodiumhydrogen
exchang
cytokin
monocyt
chemoattract
protein
ang
ii
also
elicit
immedi
increas
calcium
isol
cortic
nuclei
via
microinject
peptid
intact
epitheli
cell
find
ang
ii
directli
stimul
reactiv
oxygen
speci
ro
demonstr
enhanc
fluoresc
signatur
dichlorofluorescein
dcf
ro
format
sensit
nad
p
h
oxidas
inhibitor
diphenyleneiodonium
dpi
antagonist
losartan
blockad
phosphoinositol
protein
kinas
c
pkc
abolish
ang
stimul
ro
renal
nuclei
lieu
nuclear
local
nad
p
h
oxidas
isoform
activ
receptor
may
acut
stimul
ro
pathway
subsequ
phosphoryl
figur
studi
demonstr
nuclear
receptor
within
kidney
tissu
clearli
support
emerg
view
local
variou
gprotein
coupl
receptor
gprc
nucleu
regard
ang
ma
receptor
system
dowd
colleagu
note
canon
nuclear
local
sequenc
ma
protein
studi
traffick
local
vascular
smooth
muscl
cell
undertook
seri
studi
establish
intracellular
role
ang
cortic
tissu
proxim
tubul
isol
sheep
kidney
immunoblot
analysi
nuclei
isol
sheep
proxim
tubul
demonstr
singl
immunoreact
band
kda
util
affinitypurifi
antibodi
human
ma
protein
receptor
bind
studi
nonselect
antagonist
ang
ii
sarthran
reveal
signific
competit
receptor
antagonist
nuclei
isol
renal
cortex
function
assess
nuclear
receptor
assess
sensit
fluorophor
daf
presenc
absenc
synthas
inhibitor
lname
ang
dosedepend
increas
fluoresc
signatur
abolish
prior
treatment
lname
ang
antagonist
antagonist
receptor
consist
stimul
ang
protein
express
endotheli
nitric
oxid
synthas
eno
solubl
guanyl
cyclas
sgc
evid
isol
nuclei
sheep
proxim
tubul
data
support
previou
studi
local
eno
sgc
liver
nuclei
well
stimul
cgmp
activ
bradykinin
receptor
exact
function
ang
axi
ra
within
nucleu
known
howev
hypothes
system
may
antagon
intracellular
action
ang
pathway
address
possibl
assess
influenc
select
inhibitor
ma
receptor
antagonist
activ
ro
ang
ii
renal
cortic
nuclei
ang
depend
increas
ro
significantli
augment
similar
extent
treatment
nuclei
either
inhibitor
receptor
antagonist
increas
stimul
ro
suggest
convers
ang
antagon
action
ang
axi
nucleu
possibl
simpli
block
degrad
ang
ii
inhibitor
may
augment
action
ang
ii
howev
compar
effect
receptor
antagonist
suggest
distinct
role
ang
sinc
ang
antagonist
peptid
may
potenti
interact
demonstr
inhibit
nuclear
activ
assess
hplcbase
convers
ang
ii
ang
moreov
studi
suggest
process
ang
ii
ang
nuclear
membran
lead
activ
signal
pathway
distinct
ang
ii
know
howev
whether
attenu
ro
product
ang
involv
stimul
signal
pathway
previous
discuss
ang
may
attenu
action
ang
ii
growth
hormon
activ
intracellular
phosphatas
dual
specif
phosphatas
sever
class
phosphatas
includ
traffic
nucleu
howev
unknown
whether
ang
influenc
enzym
attenu
action
ang
ii
clearli
one
issu
regard
intracellular
ra
peptiderg
system
local
compon
within
cell
nucleu
compos
two
distinct
bilay
term
outer
omn
inner
inm
nuclear
membran
nuclear
pore
protein
travers
membran
domain
facilit
transport
cytosol
nuclear
matrix
contain
chromatindna
complex
portion
onm
continu
endoplasm
reticulum
er
perinuclear
space
share
er
nuclear
envelop
compris
omn
inm
invagin
nuclear
matrix
creat
nuclear
reticulum
key
regul
releas
nuclear
although
variou
studi
local
gprc
primarili
nuclear
envelop
matrix
current
unclear
peptid
ligand
target
nuclear
gprc
well
precis
coupl
receptor
signal
pathway
within
nucleu
moreov
elucid
pathway
deliv
peptid
ligand
respect
intracellular
receptor
well
intracellular
regul
normal
patholog
condit
establish
intracellular
express
angiotensin
kidney
evid
express
uptak
angiotensinogen
well
uptak
ang
ii
ang
protein
transport
megalin
addit
mediat
intern
ang
ii
may
contribut
intracellular
content
peptid
regard
intracellular
peptidas
may
potenti
process
intern
ang
ii
ang
altern
pathway
attenu
activ
stimul
cellular
action
ang
util
renal
epitheli
cell
line
find
evid
nuclear
local
angiotensinogen
figur
left
panel
consist
earlier
find
sherrod
colleagu
regard
nuclear
angiotensinogen
brain
astrocyt
isol
nuclei
sheep
proxim
tubul
interestingli
second
antibodi
direct
ang
sequenc
angiotensinogen
fail
detect
protein
nucleu
cell
suggest
enzymat
process
precursor
may
occur
compart
support
intracellular
process
pathway
renin
express
also
evid
nucleu
nrk
cell
figur
right
panel
isol
nuclei
exhibit
renin
prorenin
activ
follow
activ
trypsin
sensit
specif
renin
inhibitor
aliskiren
figur
bottom
left
panel
well
immunoreact
level
ang
ii
ang
addit
peptid
metabol
studi
isol
nuclei
reveal
direct
convers
ang
ang
essenti
abolish
select
inhibitor
cpp
metalloendopeptidas
thimet
oligopeptidas
figur
bottom
right
panel
other
report
nuclear
express
thimet
oligopeptidas
brain
well
identif
nuclear
local
sequenc
human
peptidas
cell
may
constitut
relev
cell
model
establish
pathway
contribut
intracellular
gener
action
ang
ii
ang
within
renal
epitheli
cell
altern
concept
intracellular
format
ibarra
colleagu
present
evid
anoth
model
nuclear
signal
wherebi
plasma
membran
invagin
perinuclear
area
facilit
present
intracellular
signal
igf
receptor
coupl
format
discret
nucleu
cardiomyocyt
appar
advantag
system
may
reflect
select
activ
signal
cascad
independ
intracellular
gener
peptid
ligand
latter
studi
add
anoth
potenti
mechan
complex
pathway
intracellular
receptor
system
angiotensin
peptid
well
emphas
need
addit
studi
elucid
organ
function
endeavor
elucid
intracellular
pathway
import
robust
biochem
molecular
techniqu
character
ra
overli
emphas
sever
report
rais
concern
regard
specif
commerci
antibodi
wide
util
western
immunoblot
immunocytochem
distribut
studi
importantli
studi
find
receptor
protein
band
appropri
molecular
weight
abolish
cell
tissu
sampl
util
antibodi
receptor
establish
molecular
weight
nuclear
fraction
pertain
matur
process
receptor
protein
howev
studi
laboratori
other
also
incorpor
peptid
bind
assay
quantit
receptor
densiti
affin
well
variou
antagonist
identifi
receptor
subtyp
receptor
bind
assay
also
parallel
demonstr
function
signal
pathway
ro
nuclei
sensit
receptor
antagonist
relianc
assess
mrna
receptor
may
equat
protein
express
certainli
reveal
discret
intracellular
distribut
receptor
antibodi
angiotensin
receptor
ra
compon
use
conveni
tool
character
system
howev
parallel
approach
establish
express
regul
ra
particularli
within
cell
clearli
warrant
increas
evid
influenc
earli
prenat
event
fetu
induc
greater
suscept
cardiovascular
metabol
patholog
evid
experiment
model
human
although
precis
natur
fetal
program
event
known
alter
biochem
compon
function
aspect
ra
may
constitut
import
underli
mechan
recent
studi
util
sheep
model
fetal
program
pregnant
ewe
administr
glucocorticoid
betamethason
day
gestat
regimen
parallel
dose
time
pregnant
women
typic
treat
glucocorticoid
enhanc
pulmonari
function
reduc
mortal
fetu
deliv
preterm
fetal
exposur
glucocorticoid
sheep
result
signific
reduct
nephron
number
within
kidney
increas
mean
blood
pressur
attenu
baroreflex
respons
br
control
heart
rate
increas
indic
metabol
dysfunct
adult
anim
figur
regard
function
ra
follow
glucocorticoid
exposur
acut
treatment
antagonist
candesartan
normal
blood
pressur
expos
sheep
improv
impair
br
overal
effect
pressur
control
unexpos
adult
sheep
contrast
administr
increas
blood
pressur
attenu
br
control
betamethasoneexpos
bm
sheep
suggest
loss
ang
tone
may
addit
consequ
fetal
program
event
protein
express
receptor
significantli
lower
brain
medulla
bm
sheep
compar
agematch
control
sheep
howev
protein
express
unchang
also
find
reduc
csf
level
ang
expos
sheep
well
higher
activ
ang
peptidas
figur
inde
csf
content
ang
invers
correl
ang
peptidas
activ
control
bm
sheep
figur
lower
right
panel
thu
reduc
express
receptor
increas
metabol
ang
brain
may
contribut
loss
ang
tone
bm
sheep
well
enhanc
respons
ang
pathway
glucocorticoiddepend
program
without
signific
chang
level
regard
renal
ra
fetal
program
ang
depend
stimul
sodium
excret
abrog
bm
sheep
moreov
antinatriuret
respons
ang
ii
enhanc
bm
sheep
well
reduct
renal
plasma
flow
consist
alter
renal
respons
ang
ii
ang
express
peptidas
contribut
balanc
ang
ii
ang
significantli
reduc
circul
proxim
tubul
urin
bm
adult
sheep
tubular
urinari
form
reduc
bm
sheep
suggest
regul
reduc
synthesi
peptidas
proxim
tubul
may
lead
lower
releas
shed
enzym
apic
membran
ace
neprilysin
activ
readili
detect
proxim
tubul
urin
adult
sheep
howev
activ
chang
follow
betamethason
exposur
moreov
circul
ace
activ
increas
activ
decreas
serum
bm
adult
sheep
kinet
analysi
activ
reveal
reduct
maxim
veloc
vmax
enzym
rather
chang
substrat
affin
km
suggest
reduc
protein
content
circul
data
suggest
solubl
form
enzym
serum
exhibit
similar
kinet
characterist
nativ
form
least
regard
metabol
ang
ii
ang
ratio
ace
also
close
correl
mean
blood
pressur
valu
control
bm
sheep
addit
alter
express
balanc
angiotensin
receptor
subtyp
chang
well
moreov
proport
ma
receptor
subtyp
lower
renal
cortex
expos
group
howev
subtyp
predomin
angiotensin
receptor
renal
medulla
receptor
subtyp
unchang
control
expos
sheep
data
emphas
select
effect
fetal
glucocorticoid
exposur
express
ra
compon
within
differ
tissu
compart
intracellular
studi
ang
ii
ang
signal
pathway
support
overal
find
express
angiotensin
receptor
subtyp
alter
follow
glucocorticoid
exposur
isol
nuclei
real
cortex
gener
ang
markedli
reduc
expos
sheep
contrast
ang
iidepend
stimul
ro
via
receptor
augment
renal
nuclei
bm
sheep
furthermor
addit
antagonist
exacerb
product
ro
ang
ii
augment
respons
particularli
evid
glucocorticoidexpos
group
clear
whether
receptor
exhibit
function
antagon
receptor
influenc
ro
format
subtyp
sequest
ang
ii
receptor
given
higher
ratio
site
sheep
cortex
final
fetal
program
event
may
convey
greater
sensit
addit
stressor
insult
particularli
anim
age
therefor
recent
studi
ascertain
renal
respons
ang
control
glucocorticoidexpos
adult
sheep
follow
remov
one
kidney
contrast
intact
nonexpos
sheep
ang
infus
reduc
sodium
excret
uninephrectom
anim
antinatriuret
respons
ang
enhanc
receptor
antagonist
subsequ
block
antagonist
candesartan
moreov
expos
anim
still
exhibit
attenu
natriuret
respons
combin
ang
candesartan
comparison
unexpos
control
group
similar
hemodynam
respons
also
observ
ang
uninephrectom
anim
wherebi
peptid
alon
reduc
blood
flow
combin
ang
candesartan
increas
flow
howev
overal
vascular
respons
similar
control
expos
anim
certainli
differ
speci
sex
primari
immort
statu
cell
dose
peptid
antagonist
durat
treatment
may
influenc
function
action
ang
receptor
mediat
effect
regard
studi
uninephrectom
sheep
differenti
respons
sodium
handl
ang
like
reflect
compensatori
mechan
remain
kidney
accommod
mark
increas
cardiac
output
fluid
handl
fascin
aspect
renal
studi
plastic
ang
respons
appar
encompass
receptor
interact
reduc
sodium
excret
uninephrectom
anim
well
ma
receptor
interact
stimul
sodium
excret
intact
sheep
moreov
natriuret
respons
ang
potenti
mediat
ma
receptor
remain
intact
uninephrectom
sheep
sinc
unmask
blockad
antagonist
howev
mechan
underli
function
interact
ang
receptor
singl
kidney
known
well
whether
ang
stimul
signal
pathway
ident
ang
axi
reduc
sodium
reabsorpt
renal
blood
flow
experiment
clinic
evid
suggest
import
influenc
sex
develop
cardiovascular
diseas
may
reflect
regul
ra
gonad
hormon
includ
testosteron
estrogen
women
gener
thought
protect
cardiovascular
patholog
time
menopaus
suggest
benefici
effect
estradiol
howev
sever
larg
clinic
trial
util
estrogen
combin
estrogenprogesteron
replac
older
women
underli
cardiovascular
diseas
reveal
advers
effect
either
treatment
experiment
studi
larg
focus
role
estrogen
influenc
aceang
axi
ra
gener
reveal
inhibitori
effect
express
ace
receptor
estrogen
deplet
ovariectomi
young
rat
markedli
exacerb
hypertens
essenti
abolish
sex
differ
blood
pressur
male
femal
congen
model
estradiol
replac
treatment
antagonist
olmesartan
normal
blood
pressur
suggest
loss
estrogen
may
lead
dysregul
ra
inde
circul
level
ang
ii
ace
activ
higher
estrogendeplet
plasma
level
ang
reduc
overal
ratio
ang
ii
ang
increas
brosnihan
colleagu
origin
propos
protect
effect
estrogen
may
part
reflect
shift
balanc
circul
ang
ii
ang
may
aris
inhibitori
effect
steroid
ace
promot
ang
express
via
increas
synthesi
andor
reduc
metabol
peptid
rel
studi
assess
tissu
differ
ang
ii
ang
male
femal
kidney
hypertens
rat
tissu
content
ang
ii
twofold
higher
male
figur
convers
renal
level
ang
threefold
lower
male
compar
femal
interestingli
cortic
activ
higher
male
perhap
suggest
compensatori
effect
buffer
higher
ang
ii
content
blood
pressur
evid
male
figur
contrast
cortic
neprilysin
activ
protein
express
significantli
higher
femal
congen
compar
male
higher
content
endopeptidas
may
contribut
differenti
express
angiotensin
femal
kidney
favor
enhanc
convers
ang
ang
well
metabol
ang
ii
ang
cardiac
activ
also
significantli
higher
male
congen
howev
tissu
level
ang
ii
ang
differ
male
femal
renal
content
ang
also
higher
femal
shr
compar
male
howev
tissu
level
ang
ii
differ
although
studi
determin
peptidas
express
shr
kidney
potenti
mechan
higher
ang
content
tissu
level
ang
higher
femal
follow
ang
ii
treatment
perhap
suggest
greater
process
ang
ii
ang
sandberg
colleagu
assess
sex
differ
express
mous
kidney
use
four
core
approach
distinguish
effect
sex
chromosom
ovarian
steroid
consist
result
rat
renal
activ
express
higher
male
mice
ovariectomi
increas
express
femal
kidney
estradiol
replac
reduc
peptidas
male
femal
howev
influenc
gonad
steroid
either
cardiac
pulmonari
data
suggest
least
nonpatholog
condit
estrogen
exhibit
inhibitori
influenc
kidney
rais
issu
whether
respons
contribut
deleteri
effect
estrogen
replac
older
women
cassi
colleagu
report
sexdepend
express
circul
ang
mice
fed
high
fat
hf
diet
male
exhibit
mark
declin
plasma
level
ang
associ
higher
circul
ang
ii
howev
plasma
level
ang
increas
hffed
femal
interestingli
ovariectomi
hffed
femal
mice
reduc
circul
ang
activ
adipos
tissu
influenc
renal
fall
circul
ang
associ
mark
increas
nocturn
blood
pressur
moreov
administr
increas
blood
pressur
femal
mice
maintain
hf
diet
suggest
ma
axi
may
buffer
obesityinduc
hypertens
greater
extent
femal
regard
ang
receptor
express
ma
receptor
increas
femal
male
follow
infus
ang
ii
may
explain
attenu
blood
pressur
ang
ii
femal
pretreat
receptor
antagonist
enhanc
blood
pressur
respons
ang
ii
femal
shr
similar
find
recent
report
aldosteron
saltsensit
model
mrna
level
ma
receptor
increas
respect
lamina
terminali
lt
femal
rat
chronic
icv
treatment
antagonist
markedli
augment
blood
pressur
respons
intact
femal
treat
aldosteron
sodium
chlorid
moreov
ovariectomi
exacerb
blood
pressur
respons
aldosteronesalt
howev
mrna
express
ma
receptor
lt
area
chang
suggest
inabl
upregul
central
ang
axi
contribut
increas
blood
pressur
model
denton
colleagu
report
alon
decreas
renal
blood
flow
femal
male
normotens
wistar
rat
although
antagonist
influenc
renal
respons
acut
ang
ii
infus
either
sex
separ
studi
mrna
level
ma
protein
markedli
higher
kidney
adult
femal
rat
compar
male
interestingli
ma
express
tend
declin
male
kidney
mrna
level
receptor
increas
femal
postnat
period
day
studi
sheep
model
fetal
program
also
provid
evid
sex
differ
respons
ang
although
exposur
betamethason
result
similar
increas
blood
pressur
reduct
nephron
number
male
femal
sheep
renal
respons
ang
antagonist
differ
sex
acut
infus
ang
result
robust
natriuret
respons
control
femal
adult
male
moreov
betamethason
exposur
associ
reduc
natriuresi
male
without
ang
treatment
significantli
blunt
natriuret
action
ang
femal
time
mechan
underli
sexdepend
effect
ang
sodium
excret
control
betamethasoneexpos
sheep
known
specul
may
involv
alter
express
signal
ma
receptor
tubular
element
kidney
current
review
examin
sever
aspect
recent
literatur
nonclass
altern
ma
receptor
axi
ra
mount
biochem
function
evid
clearli
support
tenet
pathway
may
antagon
aceang
arm
ra
either
directli
metabol
ang
ii
ang
via
distinct
pathway
limit
activ
ang
signal
inde
demonstr
intracellular
ma
axi
attenu
ang
iidepend
stimul
ro
renal
nuclei
keep
concept
balanc
ra
even
within
cell
emphas
import
target
intracellular
system
therapeut
approach
enhanc
function
ratio
ang
ang
ii
evid
alter
ang
system
within
brain
kidney
follow
antenat
glucocorticoid
exposur
implic
interact
ang
ii
ang
pathway
contribut
promot
cardiovascular
dysfunct
associ
fetal
program
event
final
sex
differ
appar
blood
pressur
regul
cardiovascular
patholog
may
reflect
alter
ma
receptor
axi
ra
addit
effect
typic
associ
aceang
pathway
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
